Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases.
Novo Nordisk Global Disease areas Science & technology Partnering Sustainable business Careers About us Our products Patients Investors Healthcare professionals News & media Contact us Disclaimer statement I do not agree I agree Warning! Ok Cancel ...
Novo Nordisk Global Disease areas Science & technology Partnering Sustainable business Careers About us Our products Investors News & media Patient help Healthcare professionals Contact us Disclaimer statement I do not agree I agree Warning! Ok Cancel ...
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases.
Learn all about Novo Nordisk in the U.S. and how we're helping to defeat diabetes, rare bleeding disorders, growth hormone-related disorders, and obesity.
Please be aware thatNovo Nordisk will be discontinuing Levemir®in the U.S. Levemir®FlexPen®and vial will be discontinued on December 31, 2024 Our top priority is always the health and safety of the patients that use our products. After careful consideration, we made this decision becau...
Novo Nordisk is committed to helping you support your patients' diabetes treatment needs, with savings cards offered through NovoCare® that provide a lower prescription co-pay for eligible patients.
Novo Nordisk is a healthcare company that operates within the healthcare and pharmaceutical sectors. The company focuses on diabetes care, obesity treatment, and management of other chronic diseases through the development of medicinal products. Novo Nordisk serves the healthcare industry, offering produ...
Novo Nordisk employs about 54,400 people in 80 countries and markets its products in around 170 countries. For more information visit novonordisk.com.Our US Research & Development hub, located in the Greater Boston area, brings together the best talent to drive life science innovation. Located ...
In 2021, Novo Nordisk voluntarily recalled more than 1,400 product samples due to improper storage. The recalled samples were marketed under the brand names Fiasp, NovoLog, Tresiba, and Xultophy. The recall involved only samples, not prescribed products distributed by retail or mail-order pharmac...